Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis

Ling, Shuo-Chien, Polymenidou, Magdalini, Cleveland, Don W.·2013·Neuron
DOI 10.1016/j.neuron.2013.07.033

Cited by (1,002)

Items 701–800 of 1,002

  1. A conserved role for the ALS-linked splicing factor SFPQ in repression of pathogenic cryptic last exons
    Patricia M. Gordon, Fursham Hamid, Eugene V. Makeyev, Corinne Houart · 2021 · Nature Communications
  2. Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?
    Cyril Quessada, Alexandra Bouscary, Frédérique René, Cristiana Valle, Alberto Ferri, Shyuan Thieu Ngo, Jean‐Philippe Loeffler · 2021 · Cells
  3. Dysregulation of Translation in TDP-43 Proteinopathies: Deficits in the RNA Supply Chain and Local Protein Production
    Reed T. Bjork, Nicholas P. Mortimore, Suvithanandhini Loganathan, Daniela C. Zarnescu · 2022 · Frontiers in Neuroscience
  4. Swimming against ALS: How to model disease in zebrafish for pathophysiological and behavioral studies
    Nuno A. S. Oliveira, Brígida R. Pinho, Jorge M. A. Oliveira · 2023 · Neuroscience & Biobehavioral Reviews
  5. Diabetic polyneuropathy, sensory neurons, nuclear structure and spliceosome alterations: a role for CWC22
    Masaki Kobayashi, Ambika Chandrasekhar, Chu Cheng, Jose A. Martinez, Hilarie Ng, Cristiane Lucia Rodriguez de la Hoz, Douglas William Zochodne · 2017 · Disease Models & Mechanisms
  6. Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
    Xiaoqiang Tang, Arturo Toro, T. G. Sahana, Junli Gao, Jessica L Chalk, Björn Oskarsson, Ke Zhang · 2020 · Molecular Neurodegeneration
  7. Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signaling
    Preeti Yadav, Bhuvaneish Thangaraj Selvaraj, Florian L. P. Bender, Marcus Behringer, Mehri Moradi, Rajeeve Sivadasan, Benjamin Dombert, Robert Blum, Esther Asan, Markus Sauer et al. · 2016 · Acta Neuropathologica
  8. Calpain-dependent disruption of nucleo-cytoplasmic transport in ALS motor neurons
    Takenari Yamashita, Hitoshi Aizawa, Sayaka Teramoto, Megumi Akamatsu, Shin Kwak · 2017 · Scientific Reports
  9. Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis
    Smriti Sangwan, David S Eisenberg · 2016 · Postępy Biochemii
  10. Enteroviral Infection Leads to Transactive Response DNA-Binding Protein 43 Pathology in Vivo
    Yuan Chao Xue, Chelsea M. Ruller, Gabriel Fung, Yasir Mohamud, Haoyu Deng, Huitao Liu, Jingchun Zhang, Ralph Feuer, Honglin Luo · 2018 · American Journal Of Pathology
  11. Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models
    Laurent Coudert, Takashi Nonaka, E Bernard, Masato Hasegawa, Laurent Schaeffer, Pascal Leblanc · 2019 · Cellular and Molecular Life Sciences
  12. A concise review of human brain methylome during aging and neurodegenerative diseases
    Prasad G, Renuka, Jho, Eek-hoon · 2019 · BMB Reports
  13. Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover
    Guangbo Liu, Aaron T. Byrd, Fen Pei, Allison Buchanan, Eman Basha, Amanda Warner, J. Ross Buchan · 2019 · Molecular and Cellular Biology
  14. Dysfunctional RNA‐binding protein biology and neurodegeneration in experimental autoimmune encephalomyelitis in female mice
    Hannah E. Salapa, Cole D. Libner, Michael C. Levin · 2019 · Journal of Neuroscience Research
  15. Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP‐43‐related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS)
    Gabriela Liseth Vaca-Altamirano, Loreto Martínez‐González, Ana Fernandez, Elisa Rojas‐Prats, Gracia Porras, Eva P. Cuevas, Carmen Gil, Ana Martı́nez, Ángeles Martín‐Requero · 2020 · Journal of Neurochemistry
  16. Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling
    Daisy Sproviero, Stella Gagliardi, Susanna Zucca, Maddalena Arigoni, Marta Giannini, Maria Garofalo, Valentina Fantini, Orietta Pansarasa, Micol Avenali, Matteo Cotta Ramusino et al. · 2022 · Frontiers in Aging Neuroscience
  17. Functional implication of ubiquitinating and deubiquitinating mechanisms in TDP-43 proteinopathies
    Non-Nuoc Tran, Byung‐Hoon Lee · 2022 · Frontiers in Cell and Developmental Biology
  18. Isolation of Exosomes and Microvesicles from Cell Culture Systems to Study Prion Transmission
    Pascal Leblanc, Zaira E. Arellano-Anaya, E Bernard, Laure Gallay, Monique Provansal, Sylvain Lehmann, Laurent Schaeffer, Graça Raposo, Didier Vilette · 2016 · Methods in molecular biology
  19. Pathomechanism Heterogeneity in the Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disease Spectrum: Providing Focus Through the Lens of Autophagy
    Rebecca Casterton, Rachel J. Hunt, Manolis Fanto · 2020 · Journal of Molecular Biology
  20. SUMO2/3 conjugation of TDP-43 protects against aggregation
    Enza Maria Verde, Francesco Antoniani, Laura Mediani, Valentina Secco, Samuele Crotti, Maria Celidea Ferrara, Jonathan Vinet, Aleksandra V. Sergeeva, Xiao Yan, Carsten Hoege et al. · 2025 · Science Advances
  21. TDP-43—The key to understanding amyotrophic lateral sclerosis
    Zuoshang Xu, Chunxing Yang · 2014 · Rare Diseases
  22. Theory of Mind and Its Neuropsychological and Quality of Life Correlates in the Early Stages of Amyotrophic Lateral Sclerosis
    Francesca Trojsi, Mattia Siciliano, Antonio Russo, Carla Passaniti, Cinzia Femiano, Teresa Ferrantino, Stefania De Liguoro, Luigi Lavorgna, Maria Rosaria Monsurrò, Gioacchino Tedeschi et al. · 2016 · Frontiers in Psychology
  23. Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43A315T ALS/FTD mouse model
    Leslie Bargsted, Danilo B. Medinas, Francisca Martínez Traub, Pablo Rozas, Natalia Muñoz, Melissa Nassif, Carolina Jerez, Alejandra Catenaccio, Felipe A. Court, Claudio A. Hetz et al. · 2017 · Scientific Reports
  24. The emerging role of minor intron splicing in neurological disorders
    Daniel Jutzi, Maureen V. Akinyi, Jonas Mechtersheimer, Mikko J. Frilander, Marc‐David Ruepp · 2018 · Cell Stress
  25. Ataxin‐2: A versatile posttranscriptional regulator and its implication in neural function
    Jongbo Lee, Minjong Kim, Taichi Q. Itoh, Chunghun Lim · 2018 · Wiley Interdisciplinary Reviews - RNA
  26. Pathogenesis of Frontotemporal Lobar Degeneration: Insights From Loss of Function Theory and Early Involvement of the Caudate Nucleus
    Gen Sobue, Shinsuke Ishigaki, Hirohisa Watanabe · 2018 · Frontiers in Neuroscience
  27. The Folding and Aggregation Energy Landscapes of Tethered RRM Domains of Human TDP-43 Are Coupled via a Metastable Molten Globule-like Oligomer
    Meenakshi Pillai, Santosh Kumar Jha · 2018 · Biochemistry
  28. The Hitchhiker’s Guide to Nucleocytoplasmic Trafficking in Neurodegeneration
    Stephen R. Moore, Benjamin E. Rabichow, Rita Sattler · 2020 · Neurochemical Research
  29. Altered Phase Separation and Cellular Impact in C9orf72-Linked ALS/FTD
    Daniel A. Solomon, Rebekah Smikle, Matthew J. Reid, Sarah Mizielinska · 2021 · Frontiers in Cellular Neuroscience
  30. Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD+ balance as a therapeutic strategy
    Mukesh Gautam, Aksu Günay, Navdeep S. Chandel, P. Hande Özdinler · 2022 · Scientific Reports
  31. Proteostasis Perturbations and Their Roles in Causing Sterile Inflammation and Autoinflammatory Diseases
    Jonas Johannes Papendorf, Elke Krüger, Frédéric Ebstein · 2022 · Cells
  32. Distinct cell type-specific protein signatures in GRN and MAPT genetic subtypes of frontotemporal dementia
    Suzanne S. M. Miedema, Merel O. Mol, Frank Koopmans, David Hondius, Pim van Nierop, Kevin Menden, Christina F. de Veij Mestdagh, Jeroen van Rooij, Andrea B. Ganz, Iryna Paliukhovich et al. · 2022 · Acta Neuropathologica Communications
  33. SBT-272 improves TDP-43 pathology in ALS upper motor neurons by modulating mitochondrial integrity, motility, and function
    Mukesh Gautam, Barış Genç, Benjamin Helmold, Angela Ahrens, Janis Kuka, Marina Makrecka‐Kuka, Aksu Günay, Nuran Koçak, Izaak R. Aguilar-Wickings, Dennis Keefe et al. · 2023 · Neurobiology of Disease
  34. Multisystem proteinopathies (MSPs) and MSP‐like disorders: Clinical‐pathological‐molecular spectrum
    Pitcha Chompoopong, Björn Oskarsson, Nicolas N. Madigan, Igal Mirman, Jennifer M. Martinez‐Thompson, Teerin Liewluck, Margherita Milone · 2023 · Annals of Clinical and Translational Neurology
  35. Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
    Fabiola De Marchi, Toni Franjkic, Paride Schito, Tommaso Russo, Jerneja Nimac, Anna A. Chami, Angelica Mele, Lea Vidatic, Jasna Križ, Jean‐Pierre Julien et al. · 2023 · Biomedicines
  36. Loss of RAD-23 Protects Against Models of Motor Neuron Disease by Enhancing Mutant Protein Clearance
    Angela Marie Jablonski, Todd Lamitina, Nicole F. Liachko, Mariangela Sabatella, Jiayin Lu, Lei Zhang, Lyle W. Ostrow, Preetika Gupta, Chia-Yen Wu, Shachee Doshi et al. · 2015 · Journal of Neuroscience
  37. Side of Limb-Onset Predicts Laterality of Gray Matter Loss in Amyotrophic Lateral Sclerosis
    Qiuli Zhang, Cuiping Mao, Jiaoting Jin, Chen Niu, Lijun Bai, Jingxia Dang, Ming Zhang · 2014 · BioMed Research International
  38. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD
    Marc Shenouda, Ashley B. Zhang, Anna Weichert, Janice Robertson · 2018 · Advances in neurobiology
  39. Phenotypic heterogeneity of astrocytes in motor neuron disease
    Emiliano Trías, Luis Barbeito, Koji Yamanaka · 2018 · Clinical and Experimental Neuroimmunology
  40. Diagnostic and prognostic values of PBMC proteins in amyotrophic lateral sclerosis
    Silvia Luotti, Laura Pasetto, Luca Porcu, Valter Torri, Saioa R. Elezgarai, Serena Pantalone, Melania Filareti, Massimo Corbo, Christian Lunetta, Gabriele Mora et al. · 2020 · Neurobiology of Disease
  41. Biological Spectrum of Amyotrophic Lateral Sclerosis Prions
    Magdalini Polymenidou, Don W. Cleveland · 2017 · Cold Spring Harbor Perspectives in Medicine
  42. Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo
    Henrick Riemenschneider, Francesca Simonetti, Udit Sheth, Eszter Katona, Stefan Roth, Saskia Hutten, Daniel Farny, Meike Michaelsen, Brigitte Nuscher, Michael K. Schmidt et al. · 2023 · Acta Neuropathologica Communications
  43. Organoids as preclinical models of human disease: progress and applications
    Baodan Chen, Cijie Du, Mengfei Wang, Jingyi Guo, Xingguo Liu · 2024 · Medical Review
  44. Inter-domain interactions of TDP-43 as decoded by NMR
    Yuanyuan Wei, Liangzhong Lim, Lu Wang, Jianxing Song · 2016 · Biochemical and Biophysical Research Communications
  45. TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis
    Stephanie M. Williams, Galam Khan, Brent T. Harris, John Ravits, Michael R. Sierks · 2017 · BMC Neuroscience
  46. Evidence of A Negative Feedback Network Between TDP-43 and miRNAs Dependent on TDP-43 Nuclear Localization
    Zachary C. E. Hawley, Danae Campos‐Melo, Michael Joseph Strong · 2020 · Journal of Molecular Biology
  47. Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits
    Wan Yun Ho, Ira Agrawal, Sheue-Houy Tyan, Emma Sanford, Wei‐Tang Chang, Kenneth Lim, Jolynn Zu Lin Ong, Bernice Siu Yan Tan, Aung Aung Kywe Moe, Regina Yu et al. · 2021 · Acta Neuropathologica Communications
  48. TDP-43 Regulation of AChE Expression Can Mediate ALS-Like Phenotype in Zebrafish
    Maria‐Letizia Campanari, Anca Marian, Sorana Ciura, Edor Kabashi · 2021 · Cells
  49. Dr. Jekyll and Mr. Hyde? Physiology and Pathology of Neuronal Stress Granules
    Pureum Jeon, Jin A Lee · 2021 · Frontiers in Cell and Developmental Biology
  50. The amyloid state of proteins: A boon or bane?
    Md Nadir Hassan, Faisal Nabi, Asra Nasir Khan, Murtaza Shabbir Hussain, Waseem Ahmad Siddiqui, Vladimir Nikolaevich Uversky, Rizwan Hasan Khan · 2022 · International Journal of Biological Macromolecules
  51. Dorsomedial prefrontal hypoexcitability underlies lost empathy in frontotemporal dementia
    Hannah L. Phillips, Huihui Dai, So Yoen Choi, Karen R. Jansen‐West, Alexis S. Zajicek, Luke Daly, Leonard Petrucelli, Fen‐Biao Gao, Wei‐Dong Yao · 2023 · Neuron
  52. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases
    Yu‐Ting Weng, Yao‐Ming Chang, Yijuang Chern · 2023 · International Journal of Molecular Sciences
  53. Early Alterations in Structural and Functional Properties in the Neuromuscular Junctions of Mutant FUS Mice
    Marat A. Mukhamedyarov, Хабибрахманов Айдар Назимович, Venera F. Khuzakhmetova, А. R. Giniatullin, Guzalia F. Zakirjanova, Nikita V. Zhilyakov, Kamilla A. Mukhutdinova, Dmitry V. Samigullin, P. N. Grigoryev, A. Zakharov et al. · 2023 · International Journal of Molecular Sciences
  54. Aggregate formation prevents dTDP-43 neurotoxicity in the Drosophila melanogaster eye
    Lucia Cragnaz, Raffaela Klima, Nataša Skoko, Mauricio Budini, Fabian M. Feiguin, Francisco Ernesto Baralle · 2014 · Neurobiology of Disease
  55. Modeling axonal defects in hereditary spastic paraplegia with human pluripotent stem cells
    Kyle R. Denton, Chongchong Xu, Harsh Shah, Xue Jun Li · 2016 · Frontiers in Biology
  56. Novel neuromuscular junction model in 2D and 3D myotubes co-cultured with induced pluripotent stem cell-derived motor neurons
    Kantaro Yoshioka, Akira Itô, Yoshinori Kawabe, Masamichi Kamihira · 2019 · Journal of Bioscience and Bioengineering
  57. Status of ALS treatment, insights into therapeutic challenges and dilemmas
    Khamaysa, Mohammed, Pradat, Pierre-François · 2022 · Journal of Personalized Medicine
  58. Cerebrospinal fluid and blood exosomes as biomarkers for amyotrophic lateral sclerosis; a systematic review
    Shahram Darabi, Armin Ariaei, Auob Rustamzadeh, Dariush Afshari, Enam Alhagh Charkhat Gorgich, Leila Darabi · 2024 · Diagnostic Pathology
  59. An age-related reduction of brain TBPH/TDP-43 levels precedes the onset of locomotion defects in a Drosophila ALS model
    Lucia Cragnaz, Raffaella Klima, Laura De Conti, Giulia Romano, Fabian M. Feiguin, Emanuele Buratti, Marco Baralle, Francisco Ernesto Baralle · 2015 · Neuroscience
  60. Protein aggregation and prionopathies
    Marianne L. Renner, Ronald Melki · 2014 · Pathologie Biologie
  61. Engineering Duplex RNAs for Challenging Targets: Recognition of GGGGCC/CCCCGG Repeats at the ALS/FTD C9orf72 Locus
    Jiaxin Hu, Jing Liu, Liande Li, Keith T. Gagnon, David R. Corey · 2015 · Chemistry & Biology
  62. Early Metastable Assembly during the Stress-Induced Formation of Worm-like Amyloid Fibrils of Nucleic Acid Binding Domains of TDP-43
    Meenakshi Pillai, Santosh Kumar Jha · 2020 · Biochemistry
  63. Modeling UBQLN2-mediated neurodegenerative disease in mice: Shared and divergent properties of wild type and mutant UBQLN2 in phase separation, subcellular localization, altered proteostasis pathways, and selective cytotoxicity
    Lisa M. Sharkey, Stephanie S. Sandoval-Pistorius, Shannon J. Moore, Julia E. Gerson, Robert Komlo, Svetlana Fischer, Keyshla Y. Negron-Rios, Emily V. Crowley, Francisco Padrón, Ronak Patel et al. · 2020 · Neurobiology of Disease
  64. TDP-43 induces EMT and promotes hepatocellular carcinoma metastasis via activating Wnt/β-catenin signaling pathway.
    Feixia Guo, Hongwei Wang, Min Jiang, Qingguo Yang, Qi Xiang, Hongyin Zhou, Xuemei Hu, Kaixuan Hao, Jie Yang, Hongwen Cao et al. · 2020 · PubMed Central
  65. Metabolic brain changes across different levels of cognitive impairment in ALS: a18F-FDG-PET study
    Antonio Canosa, Cristina Moglia, Umberto Manera, Rosario Vasta, Maria Claudia Torrieri, Vincenzo Arena, Fabrizio D’Ovidio, Francesca Palumbo, Jean Pierre Zucchetti, Barbara Iazzolino et al. · 2020 · Journal of Neurology Neurosurgery & Psychiatry
  66. Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis
    Bridget C. Benson, Pamela J. Shaw, Mimoun Azzouz, J. Robin Highley, Guillaume M. Hautbergue · 2021 · Frontiers in Neuroscience
  67. Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology
    Macy L. Sprunger, Ken Lee, Brian S. Sohn, Meredith E. Jackrel · 2022 · iScience
  68. Pathogenic Mutation of TDP-43 Impairs RNA Processing in a Cell Type-Specific Manner: Implications for the Pathogenesis of ALS/FTLD
    Kent Imaizumi, Hirosato Ideno, Tsukika Sato, Satoru Morimoto, Hideyuki Okano · 2022 · eNeuro
  69. Disruption of the VAPB-PTPIP51 ER-mitochondria tethering proteins in post-mortem human amyotrophic lateral sclerosis
    Naomi Hartopp, Dawn H. W. Lau, Sandra M. Martín‐Guerrero, Andrea Markovinović, Gábor M. Mórotz, Jenny Greig, Elizabeth B. C. Glennon, Claire Troakes, Patricia Gómez‐Suaga, Wendy J. Noble et al. · 2022 · Frontiers in Cell and Developmental Biology
  70. Fibrils Emerging from Droplets: Molecular Guiding Principles behind Phase Transitions of a Short Peptide‐Based Condensate Studied by Solid‐State NMR**
    Wojciech P. Lipiński, Johannes Zehnder, Manzar Abbas, Peter Güntert, Evan Spruijt, Thomas Wiegand · 2023 · Chemistry - A European Journal
  71. Neuroimaging of HIV-associated neurocognitive disorders
    Michel E. Haziot, Silas Pereira Barbosa, José Ernesto Vidal, Francisco Tomaz Meneses de Oliveira, Augusto César Penalva de Oliveira · 2015 · Dementia & Neuropsychologia
  72. Amyotrophic Lateral Sclerosis Pathogenesis Converges on Defects in Protein Homeostasis Associated with TDP-43 Mislocalization and Proteasome-Mediated Degradation Overload
    Guang Lin, Dongxue Mao, Hugo Jozef Bellen · 2016 · Current topics in developmental biology/Current Topics in Developmental Biology
  73. Structural insight into C9orf72 hexanucleotide repeat expansions: Towards new therapeutic targets in FTD-ALS
    Vijay Kumar, Tara Kashav, Asimul Islam, Faizan Ahmad, Md. Imtaiyaz Hassan · 2016 · Neurochemistry International
  74. RNA-Targeted Therapies and Amyotrophic Lateral Sclerosis
    Stéphane Mathis, Gwendal Le Masson · 2018 · Biomedicines
  75. To Be or Not To Be…Toxic—Is RNA Association With TDP-43 Complexes Deleterious or Protective in Neurodegeneration?
    Suvithanandhini Loganathan, Erik M. Lehmkuhl, Randall J. Eck, Daniela C. Zarnescu · 2020 · Frontiers in Molecular Biosciences
  76. Harmony Lost: Cell–Cell Communication at the Neuromuscular Junction in Motor Neuron Disease
    Anastasia Gromova, Albert R. La Spada · 2020 · Trends in Neurosciences
  77. Therapeutic genetic variation revealed in diverse Hsp104 homologs
    Zachary M. March, Katelyn M. Sweeney, Hanna Kim, Xiaohui Yan, Laura M. Castellano, Meredith E. Jackrel, JiaBei Lin, Edward Chuang, Edward Gomes, Corey W. Willicott et al. · 2020 · eLife
  78. Advancements and challenges in amyotrophic lateral sclerosis
    David Robert Bradford, Kathleen E. Rodgers · 2024 · Frontiers in Neuroscience
  79. Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis
    Kiterie M. E. Faller, Helena Chaytow, Thomas Henry Gillingwater · 2025 · Nature Reviews Neurology
  80. The tumor suppressor p53 regulates autophagosomal and lysosomal biogenesis in lung cancer cells by targeting transcription factor EB
    Zengli Zhang, Hongfeng Wang, Qifeng Ding, Yufei Xing, Delai Xu, Zhonghua Xu, Tong Zhou, Bin Qian, Chenghong Ji, Xue Pan et al. · 2017 · Biomedicine & Pharmacotherapy
  81. Contribution of the Degeneration of the Neuro-Axonal Unit to the Pathogenesis of Multiple Sclerosis
    Hannah E. Salapa, Sang-Min Lee, Yoojin Shin, M. Levin · 2017 · Brain Science
  82. Xrp1 genetically interacts with the ALS-associated FUS orthologue caz and mediates its toxicity
    Moushami Mallik, Marica Catinozzi, Clemens B. Hug, Li Zhang, Marina Wagner, Julia Bussmann, Jonas Bittern, Sina Mersmann, Christian Klämbt, Hannes C. A. Drexler et al. · 2018 · The Journal of Cell Biology
  83. “STRESSED OUT”: The role of FUS and TDP-43 in amyotrophic lateral sclerosis
    Yagiz Alp Aksoy, Wei Deng, Jack J. Stoddart, Roger S. Chung, Gilles J. Guillemin, Nicholas James Cole, G. Gregory Neely, Daniel Hesselson · 2020 · The International Journal of Biochemistry & Cell Biology
  84. Walking the line: mechanisms underlying directional mRNA transport and localisation in neurons and beyond
    Reem Abouward, Giampietro Schiavo · 2020 · Cellular and Molecular Life Sciences
  85. RNA-Binding Proteins and the Complex Pathophysiology of ALS
    Wanil Kim, Do‐Yeon Kim, Kyung‐Ha Lee · 2021 · International Journal of Molecular Sciences
  86. Identification of Genetic Modifiers of TDP-43: Inflammatory Activation of Astrocytes for Neuroinflammation
    Jae‐Hong Kim, Md. Habibur Rahman, Donghwi Park, Myungjin Jo, Hyung-Jun Kim, Kyoungho Suk · 2021 · Cells
  87. CHMP2B regulates TDP-43 phosphorylation and cytotoxicity independent of autophagy via CK1
    Xue Deng, Xing Sun, Wenkai Yue, Yongjia Duan, Rirong Hu, Kai Zhang, Jiangxia Ni, Jihong Cui, Qiangqiang Wang, Yelin Chen et al. · 2021 · The Journal of Cell Biology
  88. Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers
    Tetsuya Akiyama, Yuka Mitsuhashi Koike, Leonard Petrucelli, Aaron D. Gitler · 2022 · Clinical and Translational Medicine
  89. Prionoids in amyotrophic lateral sclerosis
    Philippe Gosset, William Camu, Cédric Raoul, Alexandre Mezghrani · 2022 · Brain Communications
  90. Arg/Lys-containing IDRs are cryptic binding domains for ATP and nucleic acids that interplay to modulate LLPS
    Mei Dang, Tongyang Li, Shibo Zhou, Jianxing Song · 2022 · Communications Biology
  91. Inhibition of the MEK/ERK pathway suppresses immune overactivation and mitigates TDP-43 toxicity in a Drosophila model of ALS
    Wenkai Yue, Xue Deng, Zhao Wang, Mingsheng Jiang, Rirong Hu, Yongjia Duan, Qiangqiang Wang, Jihong Cui, Yanshan Fang · 2023 · Immunity & Ageing
  92. Intercellular transmission of pathogenic proteins in ALS: Exploring the pathogenic wave
    Frederick J. Arnold, Ashlie Nguyen, Richard Bedlack, Craig L. Bennett, Albert R. La Spada · 2023 · Neurobiology of Disease
  93. Chaperone-mediated autophagy in neuronal dendrites utilizes activity-dependent lysosomal exocytosis for protein disposal
    Katarzyna M. Grochowska, Marit Sperveslage, Rajeev Raman, Antonio Virgilio Failla, Dawid Głów, Christian Schulze, Laura Laprell, Boris Fehse, Michael R. Kreutz · 2023 · Cell Reports
  94. Synaptopathy: presynaptic convergence in frontotemporal dementia and amyotrophic lateral sclerosis
    Emma L. Clayton, Laura Huggon, Michael Alan Cousin, Sarah Mizielinska · 2024 · Brain
  95. RNA Granule Assembly and Disassembly Modulated by Nuclear Factor Associated with Double-stranded RNA 2 and Nuclear Factor 45
    Nobuyuki Shiina, Kei Nakayama · 2014 · Journal of Biological Chemistry
  96. Targeting TDP-43 in neurodegenerative diseases
    Mauricio Budini, Francisco Ernesto Baralle, Emanuele Buratti · 2014 · Expert Opinion on Therapeutic Targets
  97. A cytosine‐thymine (CT)‐rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression
    Michael William Lutz, Robert Saul, Colton L. Linnertz, Omolara-Chinue Glenn, Allen D. Roses, Ornit Chiba‐Falek · 2015 · Alzheimer s & Dementia
  98. PABPN1 suppresses TDP-43 toxicity in ALS disease models
    Ching‐Chieh Chou, Alexeeva Olga, Shizuka B. Yamada, Amy K. Pribadi, Yi Zhang, Mo Bi, Kathryn R. Williams, Daniela C. Zarnescu, Wilfried Rossoll · 2015 · Human Molecular Genetics
  99. Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects
    Jer‐Cherng Chang, David B. Morton · 2017 · PLoS ONE
  100. The RNA binding protein EWS is broadly involved in the regulation of pri-miRNA processing in mammalian cells
    Huiwu Ouyang, Kai Zhang, Kristi L. Fox-Walsh, Yang Yang, Chen Zhang, Jie Sheng Huang, Hairi Li, Yu Zhou, Xiang‐Dong Fu · 2017 · Nucleic Acids Research